1. All important data regarding serious adverse events related to the clinical trial, which has caused or may cause death or severe deterioration of the health status of participants, users or third parties involved in the study, they are recorded and notified to the National Authorities INFARMED (National Authority of Medicines and Health Products, IP) and CEIC (National Ethics Committee for Clinical Research), immediately and not more than two days from the moment in which aware of them;